Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CB-5945 for Opioid-Induced Constipation in Chronic Non-Cancer Pain
NCT01901302Phase 3Terminated
- Sponsor
- Merck & Co.
- Start
- May 2013
- Primary completion
- Feb 2014
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of bevenopran in opioid-induced constipation (OIC), sponsored by Merck & Co.. Started May 2013; status: terminated.
02
Drugs
bevenopran
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on NCT01901302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01901302.